Evidence map›Paper›PMID 36756106›Full record

ArticleSouth Asian journal of cancer2022

Dysregulated Expression of MiR-19b, MiR-25, MiR-17, WT1, and CEBPA in Patients with Acute Myeloid Leukemia and Association with Graft versus Host Disease after Hematopoietic Stem Cell Transplantation.

Mahdiyar Iravani Saadi, Fatemeh Tahmasebijaroubi, Esmat Noshadi, Raha Rahimikian, Zahed Karimi, Maryam Owjfard, Ahmad Niknam, Ehsan Nabi Abdolyousefi, Sanaz Salek, Reza Tabrizi and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in South Asian journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Mahdiyar Iravani SaadiColorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.
Fatemeh TahmasebijaroubiHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Esmat NoshadiHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Raha RahimikianDepartment of Biochemistry, Bushehr University of Medical Sciences, Bushehr, Iran.
Zahed KarimiHematology and Oncology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Maryam OwjfardClinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ahmad NiknamHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ehsan Nabi AbdolyousefiHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Sanaz SalekHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Reza TabriziHealth Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Elham JamaliHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiraz University of Medical Sciences · IRBushehr University of Medical Sciences · IRFasa University of Medical Sciences · IRIran University of Medical Sciences · IRUniversity of Applied Science and Technology · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elham Jamali

Indexed as

acute graft versus host diseaseacute myeloid leukemiachemotherapymicroRNAstem cell transplantation

Identifiers

PMID36756106
PMCPMC9902101
OpenAlexW4224871163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.